Nantes, France

Nicolas Loriant

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Myscript. Active years: 2025.


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nicolas Loriant: Innovator in Handwriting Processing

Introduction

Nicolas Loriant is a notable inventor based in Nantes, France. He has made significant contributions to the field of handwriting processing, particularly through his innovative patent. His work focuses on enhancing the way handwritten lists are processed and understood.

Latest Patents

Nicolas Loriant holds a patent for a method titled "Structural decomposition in handwriting." This patent outlines a process for handling lists written by hand. The method involves classifying text lines as distinct items, detecting patterns to identify list items, determining indentation levels, and merging items based on predefined conditions. This approach allows for the generation of a text structure data model, improving the efficiency of handwriting recognition systems.

Career Highlights

Loriant is currently associated with Myscript, a company known for its advancements in handwriting recognition technology. His role at Myscript allows him to apply his expertise in developing innovative solutions that enhance user interaction with handwritten content.

Collaborations

One of his notable coworkers is Julien Vergne, with whom he collaborates on various projects within the company. Their combined efforts contribute to the ongoing development of cutting-edge handwriting processing technologies.

Conclusion

Nicolas Loriant's work in handwriting processing exemplifies the impact of innovation in technology. His patent and contributions at Myscript highlight the importance of improving how we interact with handwritten information.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…